Paper39760461
Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells.
Panigaj M and 8 others. ACS Nano, 2025. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells. Papers, record 39760461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39760461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nucleic Acids | Major topic |
| Proteins | Major topic |
| Nanotechnology | Major topic |
| Protein Engineering | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R35 GM134864 | NIGMS NIH HHS | United States | R35GM134864 | PubMed and NIH | NIH RePORTER |
| R35 GM139587 | NIGMS NIH HHS | United States | R35GM139587 | PubMed and NIH | NIH RePORTER |
References218
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29019396 | The Promise and Challenge of In Vivo Delivery for Genome Therapeutics. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/29019396 | PubMed |
| 2 | 34476328 | High-throughput screening of nanoparticles in drug delivery. | APL Bioeng | 2021 | https://conductscience.org/library/papers/34476328 | PubMed |
| 3 | 31924752 | Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. | Nat Commun | 2020 | https://conductscience.org/library/papers/31924752 | PubMed |
| 4 | 16438677 | RNA thermometers. | FEMS Microbiol Rev | 2006 | https://conductscience.org/library/papers/16438677 | PubMed |
| 5 | 27136077 | Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch. | Nat Biotechnol | 2016 | https://conductscience.org/library/papers/27136077 | PubMed |
| 6 | 37572272 | Combining Experimental Restraints and RNA 3D Structure Prediction in RNA Nanotechnology. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/37572272 | PubMed |
| 7 | 20194121 | Logic integration of mRNA signals by an RNAi-based molecular computer. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20194121 | PubMed |
| 8 | 21102465 | The emerging field of RNA nanotechnology. | Nat Nanotechnol | 2010 | https://conductscience.org/library/papers/21102465 | PubMed |
| 9 | 15959864 | A free-running DNA motor powered by a nicking enzyme. | Angew Chem Int Ed Engl | 2005 | https://conductscience.org/library/papers/15959864 | PubMed |
| 10 | 25521794 | Triggering of RNA interference with RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles. | ACS Nano | 2015 | https://conductscience.org/library/papers/25521794 | PubMed |
| 11 | 23601651 | A LOV2 domain-based optogenetic tool to control protein degradation and cellular function. | Chem Biol | 2013 | https://conductscience.org/library/papers/23601651 | PubMed |
| 12 | 17700701 | Selection and evolution of enzymes from a partially randomized non-catalytic scaffold. | Nature | 2007 | https://conductscience.org/library/papers/17700701 | PubMed |
| 13 | 37493987 | Phenotypic screening in Organ-on-a-Chip systems: a 1537 kinase inhibitor library screen on a 3D angiogenesis assay. | Angiogenesis | 2024 | https://conductscience.org/library/papers/37493987 | PubMed |
| 14 | 38559556 | Mechanism of action of nadofaragene firadenovec-vncg. | Front Oncol | 2024 | https://conductscience.org/library/papers/38559556 | PubMed |
| 15 | 34677049 | The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field. | ACS Nano | 2021 | https://conductscience.org/library/papers/34677049 | PubMed |
| 16 | 28922553 | Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling. | Small | 2017 | https://conductscience.org/library/papers/28922553 | PubMed |
| 17 | 34405992 | Protein Assembly by Design. | Chem Rev | 2021 | https://conductscience.org/library/papers/34405992 | PubMed |
| 18 | 20190761 | Atomic accuracy in predicting and designing noncanonical RNA structure. | Nat Methods | 2010 | https://conductscience.org/library/papers/20190761 | PubMed |
| 19 | 26926528 | Multistrand Structure Prediction of Nucleic Acid Assemblies and Design of RNA Switches. | Nano Lett | 2016 | https://conductscience.org/library/papers/26926528 | PubMed |
| 20 | 33107225 | Enlightening Allostery: Designing Switchable Proteins by Photoreceptor Fusion. | Adv Biol (Weinh) | 2021 | https://conductscience.org/library/papers/33107225 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42481857 | Design and optimization of a kinase-controlled allosteric switch. | Nat Methods | 2026 | https://conductscience.org/library/papers/42481857 | PubMed |
| 41685175 | Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral-Like Immunomodulatory Responses and Potent Adjuvant Activity. | Adv Funct Mater | 2026 | https://conductscience.org/library/papers/41685175 | PubMed |
| 41640711 | Nucleic Acid Nanoparticles Redefine Traditional Regulatory Terminology: The Blurred Line between Active Pharmaceutical Ingredients and Excipients. | ACS Nano Med | 2025 | https://conductscience.org/library/papers/41640711 | PubMed |
| 41409583 | The role of bioinformatics algorithms in modern biopharmaceutical design: Progress, challenges, and future perspectives. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41409583 | PubMed |
| 41147065 | From Sequence to Response: AI-Guided Prediction of Nucleic Acid Nanoparticles Immune Recognitions. | Small | 2025 | https://conductscience.org/library/papers/41147065 | PubMed |
| 40831543 | Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy. | RNA Nanomed | 2025 | https://conductscience.org/library/papers/40831543 | PubMed |
| 40769055 | Optogenetic enzymes: A deep dive into design and impact. | Curr Opin Struct Biol | 2025 | https://conductscience.org/library/papers/40769055 | PubMed |
| 40326805 | Nucleic acid nanobiosystems for cancer theranostics: an overview of emerging trends and challenges. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40326805 | PubMed |
| 40043838 | The Evolving Landscape of Protein Allostery: From Computational and Experimental Perspectives. | J Mol Biol | 2025 | https://conductscience.org/library/papers/40043838 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39760461
GET https://conductscience.org/api/papers/v1/39760461/references?page=2